We need to evaluate two gates based on the transcript. The question asks to consider only the provided earnings call transcript. We need to answer YES only if both gates are satisfied. Gate 1: Original Signal. We need to see if there is a positive, current development in the company's business that management presents as genuinely going well or stepping up right now, and the Q&A discussion produces more concrete operating detail than the prepared remarks contained. That is, as analysts ask about that development, management's answers keep adding new, specific, present-tense substance about it. Gate 2: Improvement Filter. We need to identify the main positive, current development that management highlights and analysts probe. Decide if the primary engine of that development is chiefly something the company itself created and controls, such as a product, service, format, technology, or channel it launched; a rollout or conversion it is executing on its own timetable; unit-level economics or mix it deliberately improved; or adoption it is winning customer-by-customer through its own selling or marketing. Answer NO if the development's momentum chiefly derives from a favorable external environment. Let's analyze the transcript. The company is Agios Pharmaceuticals. They have a product PYRUKYND for PK deficiency. They have other pipeline programs. The call covers Q4 2022 and year-end results. Prepared remarks: Brian Goff talks about progress, approvals, launch of PYRUKYND, pipeline, etc. Tsveta Milanova (CCO) talks about launch progress, market access, patient numbers, etc. Cecilia Jones talks about financials. Key positive current development: The launch of PYRUKYND in PK deficiency. They report net revenue, number of patients on therapy, PEFs, etc. They also have clinical trials ongoing. In the Q&A, analysts ask about various things: sickle cell Phase 2 data, PYRUKYND launch details, reauthorizations, etc. Let's see if the Q&A adds more concrete operating detail than the prepared remarks. Prepared remarks: Tsveta said: "In the fourth quarter of 2022, which represented the third full quarter of launch, we generated $4.3 million in net PYRUKYND revenue. A total of 105 patients have now completed a PEF, including 21 in the fourth quarter of 2022, a 25% increase versus the third quarter.
Agios Pharmaceuticals, Inc.
The call grade, management's tone measured against 177,437 other calls, what changed since the quarter before, and every one of the 500 checks.
This is the current report. Unlock its call read, expected move size, and all 500 answers.
- Does the operator announce more than five questioners?
- Is there a questioner from an investment bank other than the first three analysts who ask questions?
- Does the operator mention a queue or "next question" more than three times?
- Does the operator use the phrase "next question" at least three times?
30 markers, measured against 177,437 calls
Language counted straight from the transcript, behaviour read by the 500 checks, tone above. The band is the middle half of every call we have graded; a flag means this call sits outside it.
All 500 AI checks
Q3 2024 · 500 checks
Every answer is below. Open any check to see what its YES or NO means.
YES Does an executive answer a question by describing a process rather than an outcome?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a question the executive answers with a question back to the analyst?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone compare the company to an unnamed "competitor" or "peer" rather than naming it?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use "historically" or "traditionally" while defending a current practice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is a departure, transition, or role change mentioned only in passing without a thank-you or tribute?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference a private conversation ("as I told...", "as we discussed offline")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the transcript contain the phrase "next question" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask a question spanning more than five sentences?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a question containing multiple sub-questions (three or more)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO answer a question personally after another executive initially responds?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "if you look at" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst preface a question by summarizing the company's stated results?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the word "obviously" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "guidance" in the same sentence as a specific number?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst say "congrats" or "congratulations" to management?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "scale" or "scaling" used as a verb?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst ask a question beginning with a number ("two questions", "three quick ones")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst say "thank you" before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst name two or more executives when asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "outperform," "outperformance," or "beat" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "the environment" when describing market conditions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the word "momentum" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive begin an answer with "Great question," "Thanks," or "Appreciate"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "adjusted" or "non-GAAP" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "thank you" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "with that" as a transition phrase?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "on a comparable basis" or "adjusted for"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "moving to" or "turning to" when changing topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "over to you" or "I'll turn it over"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "operator" aloud during the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone repeat the same stock phrase three or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "as you know" to introduce a claim?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker apologize without attaching a fix to the apology?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the call end without any closing statement from the CEO?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a request to move the call along or to the last question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive answer a question with another question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive mention the weather?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a negotiation currently in progress?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive describe a competitor with anything resembling respect?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator announce more than ten questioners in the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "kind of" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any question include the word "color"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO deliver the opening remarks rather than the CFO or IR head?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "if I may" or "if you don't mind"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive's first sentence include the word "revenue"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst use the word "clarification" or "clarify" in a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any question contain the phrase "color on" or "some color"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator use the phrase "our final question" before closing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "let me" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "aggressive" or "aggressively" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question referencing "the puts and takes"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "to be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include a compliment followed by "but"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the word "sequential" or "sequentially" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "with that" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "for the benefit of" or "just to remind" when restating context?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "early days"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "journey" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the speaker describe a strategy as "disciplined" without describing any trade-off?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there an apology offered to a specific analyst by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "to be honest" or "frankly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone promise to "follow up" or "take that offline" and fail to commit to when?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone on the call interrupt a colleague mid-sentence?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does someone use a personal anecdote rather than a metric to justify confidence?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "question" appear in the operator's speech more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "growth" appear at least ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "a couple of"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask about capital allocation or buybacks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management use the word "strong" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive use the phrase "we're seeing" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "opportunity" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management use the word "confident" or "confidence" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "record" appear at least twice in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "team" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management promise to follow up or take a question offline?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "we're excited about" or "we're pleased with"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Do two or more analysts from the same firm ask questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "moving forward" or "go forward"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management mention a specific number of stores, locations, or markets?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the word "folks"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive use the phrase "we believe"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the operator use the phrase "next question" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst mention a specific percentage figure in their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "quarter" appear in at least ten questions or answers during the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does at least one analyst ask a question about margins or costs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO answer the majority of analyst questions personally?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question phrased as "Can you talk about" or "Can you speak to"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO speak during the Q&A portion at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any question reference a specific quarter (e.g., "fourth quarter") by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator interrupt the Q&A to announce time is limited or that this will be the last question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question beginning with "just" (e.g., "just curious")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask about a specific dollar amount or number stated in the prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any question begin with the words "can you" or "could you"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive use the phrase "if you look at" during the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO answer at least one question without the CEO speaking first?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question containing an explicit comparison to a competitor company?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "moving on" or "next question" come from the operator?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask about capital allocation (capex, buybacks, M&A, or dividends) in one question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "color" appear (e.g., "add some color") in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear at least five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question contain the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "I think" at least three times within a single answer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive begin an answer by restating the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive's answer exceed 300 words in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO answer the first analyst question personally?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "obviously" appear in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain the word "margin" more than ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive begin an answer with "So" as the first word?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "if I may" or "if I could" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "let me" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any question contain the word "specifically"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the word "momentum" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management mention "margin" or "margins" in prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "definitely" used by any speaker?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "seasonality" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the word "robust" to describe demand, growth, or the pipeline?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the word "leverage" as a verb at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "team" when referring to employees?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive say "that said" or "having said that" to introduce a caveat?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "great question" at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we remain confident" or "we are confident"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "thank you" immediately after finishing an answer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive cite a specific dollar figure greater than one billion?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst's question contain the word "curious"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst reference a specific prior quarter by name (e.g., "last quarter")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "obviously" two or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a follow-up in the same turn after their first answer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask about a specific geographic region or market?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a question that includes the phrase "long term" or "long-term"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "margin" or "margins" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "opportunity" or "opportunities" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "we'll come back to that" or defer an answer to a follow-up?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" three or more times in the Q&A section?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "free cash flow" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "momentum"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO mention at least one specific customer segment by name (e.g., "enterprise")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "take your question" or "take the question" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst introduce themselves by name before asking their first question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "including" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management reference "the macro environment" or "macroeconomic" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive reference "our team" or "the team" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator announce more than one analyst from the same firm?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any prepared remark mention "headwinds" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "with that, I'll turn it over"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CFO use the phrase "capital allocation"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive decline to answer, citing that something will come later or is not disclosed?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask a two-part question containing the word "but"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone ask a follow-up question in the same turn after their first question is answered?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone answer "yes" or "no" as the first word of a response?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "thank you" at least ten times in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive use the phrase "if you look at" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst begin their question with "Hi" or "Hello" as a greeting?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we are excited about" without naming a number?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst reference a peer company's results or valuation?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "just to clarify" or "just to be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "headwind" or "headwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "tailwind" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the word "momentum"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "investments" appear in the context of margins or costs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention "FX" or "foreign exchange"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "efficiency" or "productivity" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank the executives or congratulate them before asking a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "great question" or "thanks for the question"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "as we said last quarter" or reference a prior call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "going forward" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "levers" when discussing actions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts by name at any point after a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "we'll take that offline" or offer to follow up after the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "committed" regarding a target?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO's prepared remarks mention "macro" or "macroeconomic"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "the vast majority"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "temporary" or "transitory" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is an analyst's question answered with "great question" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is there a questioner from an investment bank other than the first three analysts who ask questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question that includes a reference to a specific dollar figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" at least ten times across the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "thank you for taking my question" or "thanks for taking my question" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst's first sentence contain a compliment or thanks before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CFO present in both the prepared remarks and the Q&A portion of the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO personally deliver the closing remarks of the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO's prepared remarks contain the word "team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the phrase "moving on" or "with that" to transition between topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "in terms of" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO First-person singular ("I believe," "I think") used more by the CFO than the CEO.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES A single question receives answers from two different executives.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO A hedge word ("maybe," "sort of") appears inside a direct quantitative claim.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the word "obviously"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear in both prepared remarks and the Q&A section?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive defer a question to another executive by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Someone uses the word "honestly," "frankly," or "to be clear."
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "ecosystem" or "platform" without a number attached?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the transcript contain the word "certainly" three or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone begin an answer by restating or paraphrasing the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst reference a competitor by name during their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does a speaker say "let me" at least twice in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES The transcript contains an apology unrelated to financial results.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO The word "challenge" is spoken more often than "opportunity."
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "seasonality" or "seasonal" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES The phrase "as you know" appears at least twice.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the word "challenge" or "challenges" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention "weather" as a factor affecting results?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "thank you" to the analyst before answering a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "great question" or similar praise of a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO The final question is answered noticeably shorter than the opening ones.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "we remain" followed by a verb (e.g., "we remain committed")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive cite a conversation with a customer that has no verifiable specificity (unnamed, undated, unquantified)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain a sentence that begins with "What I would say is"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question mention a specific percentage or dollar figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO personally answer more questions than any other executive?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator say "our final question" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "opportunity" or "opportunities" appear at least five times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "clearly" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "leverage" appear as a verb at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's first name get used by an executive when thanking them?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the operator announce more than five questioners?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Are there more than ten analyst questions in total?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator use the phrase "our next question comes from" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Are the CEO's prepared remarks longer than the CFO's, judged by speaker turns on the transcript page?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management say "we are not going to comment on" or equivalent refusal language?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Executive corrects an analyst's premise.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO's prepared section exceed the CEO's in number of paragraphs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO personally answer more than half of the analyst questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst mention the word "margin" in their first question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Executive uses the word "excited" more than twice.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a multi-part question containing three or more distinct questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a two-part question signaled by "and also" or "and secondly"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst begin with a compliment, such as "great quarter" or "congrats"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "we said" when recalling prior statements?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst begin their turn with "thanks" or "thank you"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "headwind" or "tailwind" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "synergies" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst address a question to two or more executives by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "capital" appear at least five times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive say "we feel" rather than "we believe" or "we think"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "capital" appear in at least three different speakers' turns?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive use the phrase "over time" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "as I mentioned" or "as we said" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO open the call before any analyst questions by mentioning the macro environment?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "we are pleased" or "we're excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the word "leverage" (financial or metaphorical)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank management before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "automation" or "productivity" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "uncertainty" or "uncertainties" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "year over year" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "leverage" or "leveraging" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Currency headwinds mentioned unprompted.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "a number of" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "best-in-class" or "industry-leading"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "momentum" appear at least twice in prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "on a constant currency basis" or similar currency adjustment used?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include the phrase "just to clarify"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "the team" appear at least twice in management remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "so clearly" or "quite frankly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the phrase "we believe" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Speaker says "we don't guide" on anything.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the word "quarter" at least ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" or "macroeconomic" appear at least twice in the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "typically" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive state they will "come back to" a question or follow up later?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts for their questions at any point during Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Speaker admits being surprised by anything.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the phrase "going forward"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the phrase "going forward" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "stability" or "stable" when describing demand?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Word "normal" used about demand.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "stay tuned" or "more to come"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management describe a cost program, restructuring, or efficiency initiative by a proper name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO's prepared section mention interest expense by name or figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "volatility" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Executive mentions a hobby or personal anecdote.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "pipeline" appear without a dollar figure attached?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "the macro" or "macro environment" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "our team" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "great question" or "good question" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "we remain" followed by an adjective?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management thank analysts by name when responding?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "flexibility" or "flexible" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "takeaway," "take out," or "take rate"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Analyst compliments the team before asking a question.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use "we're" where "we are" could substitute, more than twenty times overall?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst reference the CEO or CFO by first name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "obviously" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the word "pipeline" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "moving on" or "let me turn it over" during prepared remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask a question starting with "just"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "headwind" or "headwinds" more than once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst use the phrase "to clarify"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the phrase "year over year" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive cite a conversation with a customer, partner, or employee as evidence?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question go to a named executive other than the CEO or CFO?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "to be clear" or "let me be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone mention a competitor by name without being prompted?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a question that management declines to answer directly, citing timing or disclosure constraints?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question explicitly reference the company's prior guidance or outlook?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "next question" or does the operator use the word "final" before the last question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "invest" or "investment" appear at least five times in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO handle a strategic question instead of a financial one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst flatter management within their first sentence of speaking?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask two questions when told to ask only one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "underlying" to modify a business metric?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "excited" or "pleased" at least twice in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear in the prepared remarks (not just Q&A)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "margin" used with a number attached (e.g., "400 basis points")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "record" preceding a noun (e.g., "record margin")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive answer a question by citing a competitor's actions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "macro" or "macroeconomic" appear in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenges" appear more than once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO begin an answer with "look" or "listen"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "inflation" appear anywhere in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a pause or silence acknowledged on the call ("I think we lost you")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive name a specific competitor during the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "challenges" appear at least three times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we don't break that out" in response to a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a metric as "noisy" or "lumpy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive mention a specific number of percentage points when discussing market share?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does a speaker correct a figure they themselves just stated?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO refer to a competitor by name rather than "competition" or "peers"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO mention their own tenure or years of experience unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "the team" when taking ownership would be natural?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone blame weather, holidays, or calendar quirks unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone cite a personal anecdote involving a customer conversation?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "a little bit"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the CFO the speaker for at least one analyst question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "guidance" appear in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we're excited" or "we are excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "dividend" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "invest" or "investment" used more than twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "invest" or "investment" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone cite a percentage of revenue from a specific segment?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "challenge" or "challenging" appear at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone describe cutting discretionary spending like travel or hiring?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "year over year" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "liquidity" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript mention refinancing, maturity dates, or debt coming due?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention selling assets, real estate, or equipment to raise cash?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference "the macro" or "macro environment"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "capacity" mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "our customers" rather than naming a customer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript include a question about interest expense or debt service?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "working capital" appear in a context other than a seasonality excuse?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone reference borrowing from a bank or drawing on a credit facility?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "cost" appear in the first ten sentences of prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "we remain confident" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention covenants, amendments to loan documents, or lender conversations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "with that" or "that said" to pivot?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive open their first answer by thanking the analyst?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst's question include the word "capex" or "cash flow"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "headline" or "headwinds" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "core" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst's turn contain the word "congratulations"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a question containing "how" and also "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "as we mentioned" or "as I mentioned" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Are there more than eight analyst questioners?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's question include a percentage figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's question contain the word "guidance"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO's prepared remarks exceed 1,000 words?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "if you look at"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally answer the first question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "tailwind" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the phrase "balance sheet" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO make closing remarks after the Q&A ends?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "structurally" or "secular"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator say "our next question" two or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the final questioner get an explicit closing acknowledgment from the operator ("last question" or similar)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "business as usual" or "as expected" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst preface a question with "quick" or "quickly"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive state a specific numeric percentage when answering a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "in terms of" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a question that clearly annoyed the executive, visible in the reply's abruptness?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "guidance" appear in the Q&A section?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "strong" appear more than five times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "thank you" appear more than ten times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a question containing the word "margin"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "guidance" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "thank you" appear at least ten times anywhere in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive begin an answer by restating the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask about capital allocation or share repurchases?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "challenge" or "challenging" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "opportunity" or "opportunities" appear more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a villain—market conditions, regulation, currency—that behaves consistently across the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "challenging" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "certainly" appear at least once in management's answers?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a personal, warm, or congratulatory question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "capital" appear at least five times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask a question the prepared remarks already answered?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "quarter" appear at least twenty times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any single analyst ask more than two questions during the whole call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "on a year-over-year basis" or "year over year" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "headwinds" or "tailwinds" used?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "margin" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "confidence" or "confident" spoken by any executive?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "call it" or "let's call it" before an estimate?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "going forward" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "coming back" or "circling back" to take a follow-up?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "inflation" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "we believe" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management use the phrase "going forward"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the word "robust"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "if you will" or "so to speak"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "appreciate" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "at the end of the day"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone tell a self-contained anecdote with a beginning, middle, and end?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive use the phrase "our team"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain a silence, pause, or "we'll come back to that" that never resolves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a customer, employee, or competitor as a named character with a motive?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "we're pleased" or "I'm pleased"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a moment of modesty—someone crediting luck or timing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "excited" or "exciting" used by management at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "just" five or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any question begin with "Can you" or "Could you"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "quick" or "quickly" appear in three or more analyst questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask for guidance on a metric management did not offer unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is there a question about capital allocation (buybacks, M&A, debt, or dividends)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst use the word "clarify" or "clarification"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "obviously" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management refer to a prior call or prior quarter's commentary when answering?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the word "actually" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive begin an answer with "Look," or "So,"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "challenging" or "challenges" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator run out of queued questions and close early?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst apologize or preface with "sorry" before asking?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "excited" used by the CEO more than the word "confident"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "the right" before a noun ("the right team," "the right decisions")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "guidance" appear more than five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "tailwind" or "headwind" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's question begin with a compliment or congratulation?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst apologize before or during their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Are there more questions about revenue than about costs?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "challenging" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "on a" four or more times total (e.g., "on a constant currency basis")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive answer begin with "Sure" or "Yes" followed by a comma?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "from a ... perspective" (e.g., "from a margin perspective")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "we're not going to" in response to a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management decline to answer by citing a future event ("we'll address that in..." or "at our upcoming...")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "quarter" appear at least 20 times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a mention of "FX," "currency," or "foreign exchange"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "that's right" or "that's correct" to an analyst?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "leverage" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "leverage" used at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "headwinds" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "great question" or thank the analyst before answering?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone attribute results to "the team" rather than to strategy?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "going forward"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst begin their question with "congratulations"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank management at the end of their turn?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone describe the future with "We believe" more than "We expect"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does a speaker say "normal" or "normalized" about conditions that predate any disruption mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "momentum" used without a stated metric attached to it?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "solid" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there an analogy to a machine, engine, or flywheel?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "visibility" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the phrase "base case" or "scenario" used at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "we take that seriously" or "we're very focused on"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the phrase "to your point" or "as you mentioned" used at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator say "thank you" more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management mention a specific competitor by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management say "the team" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "fundamentally" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "ahead of" precede any mention of guidance or expectations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any single speaker say "right?" as a tag question at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the phrase "on a consistent basis" or "consistently"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does a speaker begin a sentence with "To be honest" or "To be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "strategic" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker describe a business unit as "healthy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "fundamentals"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "resilient" or "resilience" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator mention a queue or "next question" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a follow-up after their initial answer ("follow-up", "second one", "just one more")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question containing the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "if you look at" before citing a number?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "last question" or "final question" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "clearly" appear anywhere in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO speak first among named executives in the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "headwind" or "headwinds" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CFO mention a specific percentage greater than ten?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "going forward" appear at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "team" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "confident" appear in any executive's remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst thank management at the start or end of their turn?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO use the word "incredibly" at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive use the word "team" to refer to company personnel?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "to your point" when answering a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive say "with that" to transition between speakers or topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "transformation" or "transformational" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "moving on" or "next question" themselves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "hedging" or say "to hedge"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst identify themselves with a two-part introduction (name and firm)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "talent" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "capacity" used more often about factories than about people?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive confess to having too much of something physical somewhere?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is a supplier or vendor mentioned by name at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive blame weather, season, or geography for a shipment or delivery issue?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
Archived AI reasoning
Earlier Artul research experiments on AGIO calls. Open a question to read the model's original reasoning.
NO Answers go deeper than the script: questioning keeps surfacing new concrete detail behind a positive development — compa
Original model output from the research archive. It may be verbose or include the model's working notes.
The user wants me to evaluate the earnings call transcript against two gates. Let me analyze carefully. GATE 1 — ORIGINAL SIGNAL The question asks: Is there a POSITIVE, CURRENT development in the company's business that management presents as genuinely going well, for which the Q&A discussion PRODUCES MORE CONCRETE OPERATING DETAIL than the prepared remarks contained? The main positive current development here is the TIBSOVO launch. In the prepared remarks, Steve Hoerter gave details: $4.5 million net sales, ~2,000 customer interactions, ~80% testing rates, >90% awareness, 100+ unique prescribers, payer mix details. Now let me look at the Q&A to see if analysts extract MORE concrete operating detail about the TIBSOVO launch: 1. Anupam Rama asks about the newly diagnosed AML dataset and testing rates. Steve responds about testing rates going from 50% to 70% to 80% — this is somewhat additive but mostly repeats what was in prepared remarks (80% was already mentioned). 2. Kennen MacKay asks about duration of therapy for IDHIFA and TIBSOVO. Steve says it's too early for TIBSOVO, and for IDHIFA no update, consistent with what was previously reported. This is NOT additive — it's a deflection. 3. John Newman asks about whether TIBSOVO duration could be quicker given physician awareness. Steve says expect similar trajectory, less to do with familiarity and more to do with patient populations. This is somewhat generic. 4. Peter Lawson asks about TIBSOVO revenues tracking vs IDHIFA and number of salespeople. Steve says mid-30s field sales personnel, no plans to scale up. This is somewhat additive (field sales count) but not deeply substantive. 5. Mohit Bansal asks about duration in newly diagnosed patients. Chris Bowden talks about approach similar to relapsed/refractory, labeling guidelines. Not really about the launch specifically. 6. Chris Shibutani asks about inventory in the net sales number. Andrew says majority of revenue is demand. This is a small addition. 7. Tyler Van Buren asks about AGILE timelines and 881 data — not about the launch. So the Q&A about TIBSOVO launch: The prepared remarks already contained substantial detail ($4.5M sales, 2,000 interactions, 80% testing, 90% awareness, 100+ prescribers, payer mix). The Q&A adds: field sales count (mid-30s), inventory characterization (majority demand), testing rate trajectory (50%→70%→80% over time).
NO Racing a clock somebody else set: management describes an outside deadline already driving the company's current work
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES or NO. Need analyze transcript. Need determine if management describes company currently working against dated deadline set by outside entity, visibly organizing operations around hitting it, payoff ahead. Let's parse. Key potential: sNDA submission for ivosidenib in newly diagnosed AML not eligible for standard therapies. "we now plan to submit a supplemental NDA by the end of January 2019" FDA accepted Real-Time Oncology Review Pilot Program. Is that externally-set deadline? FDA program? They plan to submit by end of January 2019. Is that a fixed external date? It's a regulatory submission deadline they set? "by the end of January 2019" maybe imposed by FDA? They say "The FDA has accepted our application into their Real-Time Oncology Review Pilot Program, which has enabled us to engage with the agency prior to the planned sNDA submission and may result in a more efficient review process." They plan to submit. Is that a deadline set by outside? It's a regulatory filing date, but company chooses? Usually submission date is company's plan, not external deadline. But FDA program may have timelines? Need see if management describes current work against that date. They mention "we are focused on pulling the submission together with the timeline that I spoke to earlier" in Q&A. But is it externally set? The question asks "CURRENTLY WORKING AGAINST A DATED DEADLINE THAT SOMEBODY OUTSIDE THE COMPANY HAS SET — a fixed date, window, season, or schedule imposed by a customer, partner, program, authority, or event, which the company does not control and cannot move". sNDA submission by end of January 2019 is a regulatory filing deadline? The company plans to submit; FDA doesn't set submission date. It's company's own plan. But maybe "by the end of January 2019" is a commitment to FDA? Not necessarily. Also "assuming that a regulatory package ... acceptable to EMA" for MAA submission by end of 2018. That's also company plan. Another potential: "HOVON 150 ... remains on track to initiate this quarter." That's internal? External cooperative groups? Not dated deadline. "Phase 3 CLARITY ... on track to complete enrolment in first-half 2019." Internal. "Mitapivat Pivotal Trials ... expect to complete enrollment in 2019." Internal. "Phase 2 proof-of-concept study in thalassemia ... on track to initiate by end of year." Internal. "AG-636 IND submitted" no.
NO Operating in the future tense: management treats the next, larger stage of the business as already underway, and the fir
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if the transcript shows both: (1) present already producing, and (2) bigger next stage as working assumption. The question is about a larger next stage of the company's business. The transcript discusses TIBSOVO launch, clinical trials, etc. The key is whether management talks about a larger next stage that is already being operated toward, with current activity as the base. Look for examples: TIBSOVO launch is current, with $4.5M sales. They talk about expanding indications, sNDA for newly diagnosed AML, etc. But is that a "larger next stage" that they are already operating toward? They are planning to submit sNDA, but that's conditional on approval. They talk about completing enrollment in trials, but that's future. The question asks about a trajectory where the first stage is already real and the bigger next stage is the working assumption. For example, they might say "we are launching TIBSOVO now, and we are preparing for the next stage of expanding to frontline patients" - but that is dependent on regulatory approval. The transcript says "we plan to submit a supplemental NDA" - that's a plan, not yet approved. So the bigger stage is conditional on approval. Also, they talk about AG-881, but that's early. The rare genetic disease program is in trials, not yet producing revenue. The question specifically asks: "On this call, does management talk about a LARGER NEXT STAGE of the company's business as something it is ALREADY OPERATING TOWARD — planning, preparing, scheduling, staffing, producing, or making decisions on the working assumption that this bigger stage is coming — AND is the FIRST STAGE of that same trajectory ALREADY REAL today, with management pointing to concrete current activity (actual orders, customers, shipments, deployments, work, output, or usage happening now) that the larger stage grows directly out of?" We need to find a specific trajectory. For example, TIBSOVO launch is current. The larger next stage could be expanding to newly diagnosed AML, but that requires sNDA approval. Management says they are submitting sNDA by end of January, and they are in a pilot program. But they are not yet operating toward that as a working assumption? They are preparing the submission, but the actual larger stage (selling to newly diagnosed patients) is not yet real. The first stage is relapsed/refractory AML, which is real.
NO The company is preparing for a much bigger version of itself: internal capacity being stood up ahead of the business tha
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer yes/no based on transcript. Need determine if management describes currently putting in place internal capability to operate as much larger company, building ahead of business. Need use only transcript. Let's parse. Question asks: "On this call, does management describe that the company is CURRENTLY PUTTING IN PLACE THE INTERNAL CAPABILITY TO OPERATE AS A MUCH LARGER COMPANY THAN IT IS TODAY — building out the people, capacity, systems, facilities, or organizational structure sized for a substantially bigger business — BEFORE the business that would fill that capability has fully arrived, and does management convey that this build-out is being done deliberately in anticipation of business it expects to serve rather than in response to business it already cannot handle?" Need answer YES if management's own words convey one coherent posture: investing ahead of current size, constructing shell of bigger enterprise now because believes business to fill it is coming. Need real and already in motion, ahead of business. Let's review transcript for relevant statements. David opening: "we began to lay the groundwork to support our next phase of growth in 2019 and beyond, focused on expanding indications for our wholly-owned precision medicine, TIBSOVO, also known as ivosidenib, rapidly advancing both our cancer and rare genetic disease clinical development programs and continuing to foster our rich research pipeline." This is somewhat "lay groundwork" but not concrete capability? Maybe. Commercial launch: Steve says team of senior hematology sales consultants, ~2,000 customer interactions, raising awareness. Testing rates. Reimbursement. No mention of hiring ahead. Andrew financial: R&D increased due to mitapivat pivotal program, IND enabling, research. SG&A increased due to infrastructure and commercial capabilities with launch of TIBSOVO. "increased investment in our infrastructure and commercial capabilities with the launch of TIBSOVO." Is that building ahead? It's in response to launch, current business. Not necessarily larger company. David closing: "Our 2018 progress validates Agios as an organization built to bring medicines all the way from the lab to patients, and we’re confident in our ability to do this again and again." "As you know and as I mentioned earlier, on February 1, 2019, I will transition to the role of Executive Chairman...
NO Running the company for a size the numbers don't show yet
Original model output from the research archive. It may be verbose or include the model's working notes.
The question asks whether management conveys that it is already running the company for a meaningfully larger level of business than the reported results show, with real commitments already executing and real demand already visible. Let me search the transcript for evidence of both halves: (1) COMMITMENTS ALREADY EXECUTING, SIZED BEYOND TODAY'S NUMBERS - management describing present spending, building, hiring, producing, stocking, scheduling, or otherwise committing resources at a level that matches a bigger business. Looking through the transcript, I see mentions of: - Launch of TIBSOVO - they have a field team of senior hematology sales consultants with approximately 2,000 customer interactions - They're opening new sites and enrolling patients in ACTIVATE and ACTIVATE-T trials for mitapivat - GEA registry active across 16 sites in six countries - Phase 2 proof-of-concept trial in thalassemia on track to initiate by end of year - Submitted IND for AG-636 (7th IND) - Phase 3 CLARITY trial continuing to enroll - Various trials in progress But are these commitments "sized beyond today's numbers"? The question asks about committing resources at a level that matches a bigger business than the one in reported results. Things like capacity, facilities, locations being built/opened, people being added or trained ahead of workload, inventory secured for volumes not yet shipped. The launch of TIBSOVO - the commercial team is described, but it doesn't sound like they're scaling up dramatically beyond current needs. They mention having mid-30s in field sales personnel covering all relevant targets. Looking for specific statements about expansion beyond current levels... The transcript doesn't seem to describe major capacity expansion, hiring ahead of workload, or similar commitments. (2) THE JUSTIFICATION IS BUSINESS MANAGEMENT CAN ALREADY SEE - demand that is already real. Steve Hoerter mentions 100 unique prescribers, testing rates around 80%, awareness above 90%. These are launch metrics, but the launch just started. The revenue was $4.5 million for the partial quarter. The question specifically asks about commitment "sized beyond today's numbers" - that is, management is already operating a bigger company than reported results show. I don't see management explicitly describing that they are building capacity or committing resources beyond the current scale.
NO Bought the ticket, hasn't taken the ride: the company has already paid for its next stage and is now waiting to be paid
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO based on transcript. Need identify if management describes already spent/committed resources for larger operation while return not yet arrived, payback as matter of time, large relative to company. Let's parse transcript. Company Agios. Q3 2018. TIBSOVO launch, sales $4.5M. They have invested in commercial infrastructure, sales team, etc. Also clinical programs. Need find specific "spending done, return outstanding" phenomenon. Possible candidates: - TIBSOVO launch: They have built commercial team, had 2,000 customer interactions, awareness >90%. Sales $4.5M. But is that "spending done, return outstanding"? They invested in sales force and launch, but revenue is starting. Management says initial patients more advanced, duration will increase. But is that a stage of business already paid for? They have commercial infrastructure in place, but revenue is ramping. However, is this "large relative to company"? Maybe. - Manufacturing costs expensed prior to approval: Andrew says "Based on our policy to expense cost associated with manufacture of products prior to regulatory approval. Certain TIBSOVO manufacturing costs were expensed prior to July 20, and therefore, are not included in cost of sales during current period. As a result, majority of cost of sales for Q3 were fixed period expenses, and therefore, we expect cost of sales as percentage of product revenues to decrease over time until we deplete these inventories." This is interesting: They already spent money on manufacturing inventory before approval, expensed it, and now have inventory that will be sold in future. The cost is already paid (expensed), but revenue from that inventory will come later. This is a classic "payment without payback" - they have inventory on hand (already paid for) that will be sold in future, and cost of sales will be lower as percentage as they deplete inventories. But is this large relative to company? It's about cost of sales, maybe not huge. But management describes it as a reason cost of sales will decrease over time. This is a specific outlay already made (manufacturing costs) with return (product revenue) still outstanding. However, is it "large relative to company"? Probably not material? They say "majority of cost of sales for Q3 were fixed period expenses" - meaning they expensed pre-approval manufacturing, so current cost of sales is low.
NO Free option on their own operations: management describes a real capability it already owns that could serve a second, m
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO based on transcript. Need identify if management describes company already owns/operates capability useful for second larger purpose and recently began turning second use into real business. We need parse transcript. Company Agios. They have TIBSOVO (ivosidenib) approved for relapsed/refractory AML. They now plan sNDA for newly diagnosed AML patients not eligible for standard therapies. But is that same drug already owned and operated? Yes, TIBSOVO already approved and launched for R/R AML. Now expanded to newly diagnosed AML. That's an existing working capability (drug, approval, commercial infrastructure, launch). Second use is larger indication? Newly diagnosed AML is larger than relapsed/refractory. They have data, plan to submit sNDA by end Jan 2019. They already have revenue from R/R AML ($4.5M). But the second use (newly diagnosed) is not yet approved/revenue? They have not begun converting? They submitted plan? They have FDA real-time oncology review, but no revenue yet for newly diagnosed. Need answer NO because second use is not yet real business, contingent on sNDA approval. However transcript also mentions "expanding indications" and "newly diagnosed AML patients not eligible for standard therapies" - but that's future. Also "Both of our IDH inhibitors now available to patients" - IDHIFA is from Celgene. TIBSOVO launch. Another possible capability: IDHIFA won Prix Galien. But no. Question asks: "does management describe that SOMETHING THE COMPANY ALREADY OWNS AND ALREADY OPERATES FOR ITS EXISTING BUSINESS HAS TURNED OUT TO BE USEFUL FOR A SECOND, MUCH LARGER PURPOSE — and that the company has recently BEGUN turning that second use into real business, without having had to build a new company to do it?" Need conditions. Could be pyruvate kinase activation in other anemias: mitapivat for PK deficiency (pivotal trials) and thalassemia (Phase 2 proof-of-concept to start by end of year). Existing capability is drug and clinical program? Second use thalassemia maybe larger. But not yet converting; just starting trial. Could be AG-881 pan-IDH inhibitor gained worldwide rights from Celgene, for solid tumors. Existing capability? They have IDH inhibitors, now AG-881 for low-grade glioma. But not yet business. Could be TIBSOVO for cholangiocarcinoma (solid tumor) - Phase 3 CLARITY enrolling. Not yet approved. Could be MDS. Not.
NO Paid to expand: the company's growth spending is being covered by profits or cash the business itself is already generat
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: does management convey that the company is currently funding a real expansion out of its own ongoing profits or operating cash? That is, the business as it runs today generates the money that is paying for a concrete growth push now underway, with both halves visible in management's own account: (1) self-generated means: management describes existing operations as profitably or cash-generatively covering the company's needs, such that expansion is paid for internally rather than by raising outside money; and (2) a real push underway: management describes specific growth commitments already executing. We need to look at the transcript. The company is Agios Pharmaceuticals. They have products like TIBSOVO, IDHIFA. They have revenue from product sales and royalties. They also have cash balance of $878 million. They mention that they expect this cash balance plus expected TIBSOVO revenue to fund operating plan through at least end of 2020. That suggests they are using existing cash and expected revenue, not necessarily that they are generating profits from operations to fund expansion. They are a biotech with R&D expenses, SG&A, etc. They have net losses likely. They are not profitable. They are using cash reserves. The question specifically asks: "the business as it runs today generates the money that is paying for a concrete growth push now underway" - that is, self-generated means from ongoing profits or operating cash. But the company is not profitable; they have significant R&D and SG&A expenses. They have revenue but also costs. They have cash from prior financing. They are not describing that they are funding expansion out of operating cash flow. They are using cash on hand. Also, they are not describing a concrete expansion that is being paid for by internal funds. They are launching products, but they are spending on R&D and commercial. They have a cash balance that will fund operations. That is not the same as self-funding from profits. The question also says: "Answer NO if the expansion is funded chiefly by recent or planned equity raises, new debt, or asset sales." They have cash from prior raises. They are not explicitly saying they are raising new money, but they are using existing cash. The question is about whether the business generates the money to pay for expansion.
NO The bridge is already built: management walks investors from today's numbers to a bigger business using only pieces alre
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer only YES/NO. Need analyze transcript. Need determine if management's forward story over next year built primarily out of specific pieces already secured/in motion, not hopes/pipeline/general demand. Need identify named components, near-dated, material. Let's parse. Company Agios. Q3 2018. Key updates: TIBSOVO launch, IDHIFA. Forward: sNDA for TIBSOVO in newly diagnosed AML not eligible standard therapies by end Jan 2019. FDA accepted Real-Time Oncology Review. Phase 3 AGILE revised EFS endpoint, enrollment completion 2020 (a year earlier). HOVON 150 Phase 3 initiate this quarter. MAA for ivosidenib relapsed/refractory AML by end 2018. CLARITY cholangiocarcinoma enrollment complete first-half 2019. Glioma decision by year-end. AG-270 dose escalation. AG-636 IND submitted. Mitapivat PK deficiency pivotal trials enrollment complete 2019. Thalassemia Phase 2 start by end year. TIBSOVO launch revenue $4.5M first partial quarter. Launch progress. Question: On this call, when management explains where business is heading over roughly NEXT YEAR, does it build explanation primarily out of SPECIFIC PIECES ALREADY SECURED/IN MOTION rather than market hopes/pipeline/general demand? Need answer YES if management's own words convey path from today's reported numbers to meaningfully larger/stronger near-term business as walk across pieces that already exist. Need consider if forward story includes regulatory submissions, trial initiations, enrollment completions. Are these "pieces already secured/in motion"? They are clinical development milestones, not necessarily revenue. But business includes pipeline. Need assess. The question likely from a framework about "backlog" or "secured business" vs pipeline. Here management discusses regulatory submissions, clinical trials, launch. Are these "specific pieces already secured"? sNDA submission planned, not approved. FDA accepted RTOR. That is a regulatory process, not a committed contract. But it is in motion. However, the forward story is mostly about clinical development milestones, not necessarily revenue growth. The company's business is biotech; near-term value from regulatory approvals and trial data. But the question asks "business the company has already locked in" - results understate business already locked in. Management mentions TIBSOVO launch, sNDA submission, MAA submission, trial enrollment.
NO Paid-in full, payoff just starting: the hard part of a major undertaking is behind the company, and the benefit is only
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Question: Does management convey that hardest/costliest/most uncertain phase of major undertaking is now substantially behind company, crossing from paying to getting paid, with reported results still mostly reflecting paying phase? We need use only transcript. Company Agios. Q3 2018. TIBSOVO launch. They had approval and launch of TIBSOVO in July. Net sales $4.5 million first partial quarter. They describe launch progress, testing rates, awareness. Is this "heavy lifting substantially done"? They say "The July approval and launch of TIBSOVO... was a remarkable achievement." "We're pleased with progress of U.S. launch." They have commercial team, interactions. But are they saying hardest phase behind? They are in launch, early. They have ongoing clinical development, sNDA, etc. The question asks about major undertaking: likely development and launch of TIBSOVO. Management conveys approval achieved, launch begun, revenue starting. But is heavy lifting described as substantially done? They mention "hard work and dedication culminated in achievement of important clinical and regulatory milestones" and "put us on track to complete remaining milestones." They have approval and launch. But they also have ongoing expansion, clinical trials. The reported results: $4.5 million net sales, first partial quarter. They say "pleased with progress" and "off to a great start." They expect duration increase, patient mix evolves. They don't explicitly say heavy lifting behind, costs peaked. They are still investing in R&D, SG&A increased. They have cash to fund through 2020. They are in launch phase, but not necessarily "paying phase" behind. The question asks if management conveys crossing from paying to getting paid. They have product revenue, but also collaboration revenue. They say "initial quarter of sales" and "gross-to-net in line." They don't say costs of launch are behind. They are still building. Also they have multiple programs. The "major undertaking" could be TIBSOVO development and launch. Approval achieved, launch started. But they are still spending on commercialization, clinical trials. The reported results include $4.5M revenue, but also R&D $82M, SG&A $31M. They don't say heavy phase is behind. They say "we know that our work has just begun to provide access to more patients." That suggests not behind.
NO Deliberate concentration of the whole company onto one bet that is already being built
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO based on transcript. Need determine if management conveys deliberate concentration onto one primary undertaking with resources moving and outcome rides on it. Need analyze. Transcript: Agios Pharmaceuticals. Q3 2018. They discuss multiple programs: TIBSOVO launch, IDHIFA, ivosidenib in AML frontline sNDA, AG-881, mitapivat PK deficiency, AG-270, AG-636, thalassemia, etc. Management presents broad pipeline. Is there one focal undertaking? Maybe TIBSOVO launch? But they also emphasize multiple milestones. Need assess. Question asks "ON THIS CALL, does management convey that the company has DELIBERATELY CONCENTRATED ITSELF — its capital, capacity, best people, management attention — ONTO ONE PRIMARY UNDERTAKING that it treats as the thing that will determine what the company becomes, AND is that undertaking already being physically built, staffed, or executed right now rather than merely chosen?" Need answer YES only if all three. Likely NO because company is running broad balanced set of priorities. Let's examine. David opening: "third quarter exciting time... achievement of important clinical and regulatory milestones... on track to complete remaining milestones... began to lay groundwork to support next phase of growth in 2019 and beyond, focused on expanding indications for our wholly-owned precision medicine, TIBSOVO, also known as ivosidenib, rapidly advancing both our cancer and rare genetic disease clinical development programs and continuing to foster our rich research pipeline." This lists multiple. "Notably, July approval and launch of TIBSOVO... remarkable achievement." "With both IDH inhibitors available... rewriting textbooks." "Today, we announced two key updates to ambitious clinical development strategy in newly diagnosed AML. Most importantly, plan to submit sNDA..." Then solid tumors, AG-881, mitapivat, AG-270, AG-636. This is broad. Chris covers numerous clinical initiatives across oncology and rare genetic diseases. Steve commercial update on TIBSOVO launch. Andrew financials. No single focal undertaking. They have multiple priorities. The question's essence: one primary undertaking. Management does not convey that. They are diversified operator reporting progress in many places. So answer NO. Need ensure no hidden "one thing" like "TIBSOVO" as main event? But they also have IDHIFA, mitapivat, early pipeline.
NO Analysts still asking about the old story while management keeps pointing to a new driver already producing
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Need determine if mismatch between analysts questions and management redirects to newer driver producing results. Let's parse. Company Agios. Q3 2018. Key: TIBSOVO approved/launched July 2018, net sales $4.5M. IDHIFA (enasidenib) partnered with Celgene royalty. Analysts ask about TIBSOVO launch, duration, revenues vs IDHIFA, testing rates, frontline AML strategy, AG-270, etc. Management discusses TIBSOVO launch results, sNDA for newly diagnosed AML, AGILE, etc. Question asks: "On this call, is there a clear MISMATCH between what analysts keep asking about and what management keeps pointing to — where questions remain focused on OLDER, ESTABLISHED concern or storyline about company (such as weak/declining legacy business, past losses/missteps, macro/industry worry, or core business everyone already knows), while management repeatedly redirects attention to DIFFERENT, IDENTIFIABLE part of business that it says is ALREADY producing real results today — and does management back that redirection with concrete, current evidence rather than hope?" Need answer YES only if both halves. Need identify if analysts' questions center on older established concern vs management redirects to newer driver already producing results. Hmm. Let's examine transcript. Analysts questions: - Anupam: asks about ivosidenib newly diagnosed AML dataset at ASH and how much shared with regulators; and genetic testing rates for IDH1 with TIBSOVO relative to IDH2/IDHIFA. - Kennen: MTAP program AG-270, anti-cancer activity, dosing; durations in commercial market relapsed/refractory; frontline ineligible definition. - John: duration TIBSOVO vs IDHIFA; mechanistic opportunity for monotherapy after combination. - Peter: TIBSOVO revenues vs IDHIFA, number salespeople, SG&A. - Mohit: duration in newly diagnosed ineligible; Phase 3 HOVON transplant confounding. - Terence: AG-270 PK effects, safety; total spend 2019. - Chris Shibutani: launch inventory, gross-to-net; CEO transition messaging. - Michael: TIBSOVO MDS development; AGILE enrollment timelines; HOVON; DHODH inhibitor. - Tyler: AGILE timelines, EFS/OS; AG-881 update. Management responses: - David opening: Q3 exciting, TIBSOVO approval/launch first and only treatment IDH1 mutant R/R AML. IDHIFA won Prix Galien. TIBSOVO sNDA in newly diagnosed AML. AG-881 rights. Mitapivat enrollment.
NO Small company already selling a lot to one hot market — management describes riding an outside spending wave far bigger
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES or NO based on transcript. Need determine if management describes one specific external spending surge/build-out/adoption wave current business levered to, early/accelerating, company's share small. Let's parse. Transcript: Agios Pharmaceuticals, IDH inhibitors TIBSOVO launch, AML. They discuss TIBSOVO launch, IDH mutation testing rates increasing. Is that an external adoption wave? "Increasing testing rates of the IDH mutation is a key strategic imperative for adoption of both IDH inhibitors... encouraged with steady growth... According to market research from August, just after TIBSOVO launched, approximately 80% of physicians were testing their patients for IDH1 and IDH2 mutations. We believe academic centers are screening vast majority... community is typically behind... focus on improving IDH testing rates among these prescribers." This is an adoption wave? It's testing rates, not spending surge. Company's current business tied to IDH testing adoption? They are levered to it because more testing leads to more prescriptions. But is it a named outside wave of spending/adoption? It's a diagnostic testing adoption wave by physicians. Management conveys it's still early? Community behind, focus on improving. But is it "large and identifiable share of current business"? They mention testing rates as strategic imperative, not necessarily current revenue. Also "physician awareness above 90%" etc. The question asks ONE specific external spending surge, build-out, or adoption wave happening in customers' world right now, scale/pace set by parties other than company. Could be IDH mutation testing adoption. But is it a spending surge? Testing rates increasing. Company's volumes from it expected to climb? They say testing rates around 80%, community behind, focus on improving. But not necessarily "large and growing part of what company is selling" - it's an enabler. Also they don't quantify company's share small relative to wave. Hmm. Other possibilities: Newly diagnosed AML patients not eligible for standard therapies, sNDA, expansion. But that's future regulatory, not current external wave. "AML frontline strategy" etc. Not current. Maybe "TIBSOVO launch" itself? No, that's company's own product launch, not external spending surge. Could be "IDH inhibitors rewriting textbooks" no. Need answer NO likely. But let's carefully evaluate.
NO The feared thing keeps not happening: management confronts a specific live worry with current evidence running against i
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if there is a specific negative outcome that investors/analysts/market are worried about, and if management pushes back with current, already-observed evidence. Let's analyze the transcript. The call is about Agios Pharmaceuticals. Key topics: TIBSOVO launch, IDH inhibitors, clinical trials, etc. Analysts ask questions about: - TIBSOVO revenue trajectory vs IDHIFA, duration of therapy, testing rates. - AG-270 (MAT2A inhibitor) - whether lack of anti-cancer activity is a concern. - AGILE trial enrollment timelines. - AG-881 data. Is there a specific fear? Possibly about TIBSOVO launch underperforming? But management gives updates on sales, testing rates, awareness. However, the question asks for a specific negative outcome that investors are worried about, and management pushes back with observed evidence. Let's look for a fear that is live. For example, analysts ask about duration of therapy for TIBSOVO - they might be worried that duration will be short, but management says it's early and similar to IDHIFA. That's not a specific fear. Another possibility: The fear that AG-270 has no anti-cancer activity. Analyst Kennen MacKay asks: "I'm just wondering if we should sort of anticipate you mentioned of seeing pharmacodynamic effects as expected. But sort of lack of language on anti-cancer activity or efficacy there, the signal that the anti-cancer effect is not being seen yet, or if that's just reading too much into it?" That is a specific worry: that the drug is not showing anti-cancer activity. Management responds: "I don't think you should infer anything, because as you know, our practice is that we're not going to present any clinical data until we have a complete story and we bring it to a major medical meeting. So one should not infer in either direction by our comments today." That is not pushing back with observed evidence; it's saying we won't comment. So that's not a counter with evidence. Another fear: About TIBSOVO launch - maybe the fear that sales will be low? But management gives actual sales numbers ($4.5M) and testing rates, awareness. That is observed evidence. But is there a specific fear that analysts are probing? They ask about duration, trajectory. Management says "you can expect a similar trajectory for TIBSOVO relative to IDHIFA" and notes that the landscape is changing. That's not a specific fear.
NO Management is planning the next period around a number the current business does not yet support
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management reveals that they are already resourcing and organizing the company around a level of activity that the business is not yet doing. That is, they are spending, hiring, building, etc., for a materially higher level of business than reported, and they explain this is due to specific things they can already see. Let's review the transcript. The call covers Q3 2018. They launched TIBSOVO in July 2018. They have various clinical programs. They mention expanding indications, advancing programs, etc. Key points: They talk about the launch of TIBSOVO, the progress, the sales force, etc. They mention that they have a team of senior hematology sales consultants, about 2,000 customer interactions. They talk about increasing testing rates. They mention that they are pleased with uptake. They don't seem to indicate that they are building capacity ahead of demand. They talk about the launch being early. They also mention that they are opening new sites and enrolling patients in mitapivat trials, and they anticipate completing enrollment in 2019. They are starting a Phase 2 trial in thalassemia by end of year. They have submitted an IND for AG-636. They are progressing AG-270. They talk about the sNDA for TIBSOVO in newly diagnosed AML, and they plan to submit by end of January 2019. They mention the FDA's Real-Time Oncology Review pilot. They talk about the Phase 3 AGILE study, and they are revising the protocol to reduce number of patients, and expect to complete enrollment in 2020, a year earlier. They talk about the HOVON 150 trial, which is on track to initiate this quarter. They talk about the commercial launch: they have a field team, they are increasing testing rates, etc. Now, the question: Does management reveal that they are already resourcing and organizing the company around a level of activity that the business is not yet doing? That is, are they spending, hiring, building, etc., for a materially higher level of business than reported, and they explain this is due to specific things they can already see? Look for any statements about capacity, hiring, spending, etc., that are ahead of current business. For example, if they say they are building a sales force for a larger market, or they are investing in manufacturing capacity for future demand, or they are adding staff for trials that haven't started, etc.
NO After the books closed: the quarter's biggest news happened too late to be in the numbers
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management reports that the most important positive developments of the period happened so late in the reported period or shortly after it ended that the results contain little or none of their effect, with management itself marking the timing. Let's analyze the transcript. The call is for Q3 2018. Key events: TIBSOVO approval and launch in July (which is early in Q3, not late). However, there are other developments: the sNDA submission for newly diagnosed AML planned by end of January 2019 (after quarter end), the acceleration of the Phase 3 AGILE trial, the acquisition of worldwide rights to AG-881 from Celgene in September (which is late in Q3), and the IND submission for AG-636 (submitted, but not yet started trials). Also, the upcoming ASH presentations. The question asks: "On this call, does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented contain little or none of their effect — with management itself marking the timing?" We need to see if management explicitly says that these developments happened late and that the reported results (e.g., financial results) don't reflect them. For example, the TIBSOVO launch started in July, so it's within Q3. The $4.5 million in sales is for the partial quarter. That's not late. The AG-881 rights acquisition in September is late in Q3, but that's a business development event, not a revenue-generating event. The sNDA submission is planned for January 2019, after quarter end, but that's a regulatory submission, not a revenue event. The AGILE trial enrollment completion is expected in 2020, not a current event. Management does not seem to frame any of these as "the results contain little or none of their effect." They discuss the launch progress, but they don't say that the quarter's results miss the impact of late-breaking events. They do mention that the sNDA submission is planned, but that's future. The AG-881 rights acquisition is a strategic move, but they don't say it affects the quarter's financials. The question is about "MOST IMPORTANT POSITIVE DEVELOPMENTS" and whether they happened so late that the results don't reflect them. The most important positive development is the TIBSOVO launch, which started in July, so it's within the quarter.
NO Escape velocity out of a small base: management describes the business compounding at a rate its own size cannot absorb
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management describes the company as being at a point where the rate of accumulation is the dominant fact, with multiples and small base. Let's analyze the transcript. The call covers Q3 2018 results. Key points: TIBSOVO launch, IDHIFA, clinical programs. Management discusses progress, but do they frame current activity as multiples of recent past? They mention "approximately 2,000 customer interactions" for TIBSOVO, "over 100 unique prescribers" - but these are not framed as multiples. They compare TIBSOVO awareness to IDHIFA at similar time: "awareness of TIBSOVO is already above 90%, which compares favorably to a 50% awareness of IDHIFA at a similar time in its launch." That's a comparison, but not a multiple of their own activity. They talk about testing rates increasing from 50% to 80% - that's a multiple? Actually 80% vs 50% is 1.6x, but not framed as "several times". They say "we are seeing the expected effects" etc. The question asks: does management convey that the rate of accumulation has become dominant, with multiples and small base? They do mention "we are pleased with the progress" but not in terms of multiples. They talk about "first partial quarter of launch" with $4.5M sales. They don't say "doubled" or "tripled" or "several times". They mention "over 100 unique prescribers" - but not as a multiple. They mention "approximately 2,000 customer interactions" - again not a multiple. They also discuss clinical development: "we now expect to complete enrollment in 2020, a year earlier" - that's a timeline, not a multiple. They talk about "the company’s 7th IND over the past 10 years" - that's a count, not a multiple. The essence: management does not frame current activity as multiples of recent past. They use ordinary incremental language: "steady growth", "encouraged", "pleased". They don't say "we've doubled our prescribers" or "our sales are several times what they were". They do compare to IDHIFA but that's a different product, not their own past. Also, they treat the company as still small? They mention "we are not aware of any payer-related coverage issues" etc. But they don't say "we are still small relative to what's happening". They talk about expanding indications, but not in terms of being undersized. Thus, the answer is NO. The management does not use multiples to describe current activity.
NO Cost of being wrong just collapsed: the company can now try things it previously could not afford to attempt
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO based on transcript. Need determine if management conveys that cost of attempting new thing has dramatically fallen, so company taking multiple swings now, with at least one showing results. Need look for evidence. Transcript: Agios. They have TIBSOVO launch, IDHIFA. They have multiple clinical programs. Key: "we now plan to submit supplemental NDA by end January 2019 for ivosidenib in newly diagnosed AML patients not eligible for standard therapies. FDA accepted Real-Time Oncology Review Pilot Program... may result in more efficient review process." Also "we've been able to accelerate our AML frontline strategy... FDA confirmed EFS acceptable primary endpoint for Phase 3 AGILE... study design revised to reduce number of patients required... expect complete enrollment in 2020, a year earlier than prior guidance." This is about faster/cheaper? They reduced patients needed, accelerated timeline. Also "we gained worldwide rights to AG-881... now have global rights for two IDH1 mutant inhibitors for potential treatment of low-grade glioma." They are pursuing multiple indications. But does management convey that cost of attempting new thing has fallen dramatically relative to past? They mention "Real-Time Oncology Review" may make review more efficient. They mention "we've been able to accelerate" due to FDA agreement on endpoint and reduced patients. That is a drop in cost of clinical trial? Fewer patients, faster enrollment. They are taking multiple swings: TIBSOVO in AML, MDS, cholangiocarcinoma, glioma; AG-881; mitapivat; AG-270; AG-636. But is that due to cheaper attempts? Not exactly. They have platform? They have IDH inhibitors. They have "rewriting textbooks" etc. Need see if management explicitly contrasts past vs now. They say "we've been able to accelerate our AML frontline strategy" due to FDA confirmation. That is a change in regulatory pathway, not necessarily cost of attempt. They also say "we now plan to submit sNDA" for newly diagnosed AML. This is a new indication. They have multiple trials. But is there a "real drop in cost of attempt" relative to company's own past? The transcript doesn't really say "it used to take X, now takes Y". It says "we expect to complete enrollment in 2020, a year earlier than prior guidance" due to revised study design. That is a reduction in time/patients for one trial.
Showing the latest 18 of 225 archived research questions.
These archived questions are separate from the newer 500-check scan above.
AGIO call history
Open a quarter only when you want its detailed evidence.
C Q2 2025 · Caution · 2026-04-21Management held guidance steady against accelerating demand. The delivery was rich in specifics, promotional in tone.
F Q3 2025 · Very weak call · 2026-04-21Management held guidance steady against accelerating demand. The delivery was rich in specifics, promotional in tone.
View the 20 core call-quality checks
C Q4 2025 · Caution · 2026-02-12Management held guidance steady against accelerating demand. The delivery was rich in specifics.
View the 20 core call-quality checks
C Q1 2025 · Caution · 2025-05-01Management held guidance steady against steady demand. The delivery was rich in specifics, promotional in tone.
View the 20 core call-quality checks
B Q4 2024 · Solid call · 2025-02-13Management gave no formal guidance against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.
View the 20 core call-quality checks
C+ Q3 2024 · Mixed call · 2024-10-31Management held guidance steady against accelerating demand. The delivery was unusually candid, rich in specifics.
View the 20 core call-quality checks
C Q2 2024 · Caution · 2024-08-01Management gave no formal guidance against steady demand. The delivery was unusually candid, rich in specifics, promotional in tone.
View the 20 core call-quality checks
View 35 earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|---|---|---|---|---|---|---|
| Q1 2024 | 2024-05-02 | C | maintained | accelerating | unclear | 6/9 | 3/9 |
| Q4 2023 | 2024-02-15 | C | maintained | stable | unclear | 6/9 | 3/9 |
| Q3 2023 | 2023-11-02 | D | maintained | stable | unclear | 6/9 | 3/9 |
| Q2 2023 | 2023-08-03 | C | maintained | stable | unclear | 6/9 | 4/9 |
| Q1 2023 | 2023-05-04 | C | none | accelerating | unclear | 6/9 | 3/9 |
| Q4 2022 | 2023-02-23 | C | none | accelerating | unclear | 7/9 | 2/9 |
| Q3 2022 | 2022-11-04 | D | none | accelerating | unclear | 6/9 | 5/9 |
| Q2 2022 | 2022-08-07 | D | maintained | stable | unclear | 6/9 | 5/9 |
| Q1 2022 | 2022-05-05 | F | maintained | stable | expanding | 5/9 | 6/9 |
| Q4 2021 | 2022-02-24 | C+ | none | unclear | unclear | 7/9 | 3/9 |
| Q3 2021 | 2021-11-03 | B | maintained | accelerating | unclear | 6/9 | 4/9 |
| Q2 2021 | 2021-07-30 | C+ | maintained | accelerating | unclear | 6/9 | 4/9 |
| Q1 2021 | 2021-04-29 | B | maintained | unclear | unclear | 6/9 | 3/9 |
| Q4 2020 | 2021-02-25 | C+ | maintained | accelerating | stable | 7/9 | 3/9 |
| Q3 2020 | 2020-11-05 | B+ | raised | accelerating | stable | 7/9 | 3/9 |
| Q2 2020 | 2020-07-30 | C+ | maintained | accelerating | unclear | 7/9 | 3/9 |
| Q1 2020 | 2020-04-30 | C+ | maintained | accelerating | stable | 7/9 | 3/9 |
| Q4 2019 | 2020-02-13 | B | raised | accelerating | unclear | 7/9 | 3/9 |
| Q3 2019 | 2019-11-01 | C | maintained | accelerating | unclear | 6/9 | 4/9 |
| Q3 2020 | 2019-10-31 | D | maintained | accelerating | unclear | 6/9 | 5/9 |
| Q2 2019 | 2019-08-01 | C+ | maintained | accelerating | unclear | 7/9 | 4/9 |
| Q1 2019 | 2019-05-02 | D | maintained | mixed | unclear | 7/9 | 5/9 |
| Q4 2018 | 2019-02-14 | C+ | maintained | accelerating | unclear | 7/9 | 3/9 |
| Q3 2018 | 2018-11-01 | C | maintained | accelerating | unclear | 6/9 | 5/9 |
| Q2 2018 | 2018-08-02 | C+ | maintained | stable | unclear | 6/9 | 3/9 |
| May 2018 | 2018-05-06 | C | maintained | accelerating | unclear | 6/9 | 3/9 |
| Q4 2017 | 2018-02-14 | C | maintained | accelerating | unclear | 6/9 | 5/9 |
| Q3 2017 | 2017-11-01 | D | maintained | accelerating | unclear | 6/9 | 5/9 |
| Q2 2017 | 2017-08-08 | C+ | maintained | unclear | contracting | 7/9 | 4/9 |
| Q1 2017 | 2017-05-04 | C | none | unclear | contracting | 6/9 | 4/9 |
| Q4 2016 | 2017-02-16 | C | none | accelerating | contracting | 7/9 | 4/9 |
| Q3 2016 | 2016-11-03 | F | maintained | unclear | contracting | 5/9 | 6/9 |
| Q2 2016 | 2016-08-04 | D | none | unclear | contracting | 6/9 | 5/9 |
| Q1 2016 | 2016-05-06 | F | maintained | unclear | contracting | 6/9 | 6/9 |
| Q4 2015 | 2016-02-18 | C | maintained | unclear | contracting | 7/9 | 6/9 |